CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE UNITS, STOCKHOLDERS' EQUITY AND PARTNERS' EQUITY - USD ($) $ in Thousands	Total	Class B Units	Class A Units	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Deficit Class B Units	Accumulated Deficit Class A Units
Beginning balance of redeemable convertible unit (in shares) at Jan. 31, 2025	495,161,000
Beginning balance of redeemable convertible unit at Jan. 31, 2025	$ 11,196,141
Increase (Decrease) in Temporary Equity [Roll Forward]
Vesting of incentive units into Class B Units (in shares)		3,049,000
Adjustment to reflect the redemption value of the redeemable convertible units	$ 253,531	$ 229,744	$ 23,787
Effect of Corporate Conversion (in shares)	(498,210,000)
Effect of Corporate Conversion	$ (11,449,672)
Ending balance of redeemable convertible unit (in shares) at Jul. 31, 2025	0
Ending balance of redeemable convertible unit at Jul. 31, 2025	$ 0
Common stock, Beginning balance (in shares) at Jan. 31, 2025				0
Stockholders' equity, beginning balance at Jan. 31, 2025	(5,588,440)			$ 0	$ 0	$ (5,588,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adjustment to reflect redemption value of redeemable convertible units		$ (229,744)	$ (23,787)				$ (229,744)	$ (23,787)
Equity-based compensation expense after Corporate Conversion	862				862
Net loss prior to Corporate Conversion	(19,255)					(19,255)
Effect of Corporate Conversion (in shares)				497,807,000
Effect of Corporate Conversion	11,449,672			$ 50	5,588,396	5,861,226
Issuance of common stock in connection with IPO, net of underwriters’ discounts and commissions and offering costs and tax effects (in shares)				57,500,000
Issuance of common stock in connection with IPO, net of underwriters’ discounts and commissions and offering costs and tax effects	1,251,436			$ 6	1,251,430
Equity-based compensation expense after Corporate Conversion	154,011				154,011
Issuance of common stock upon settlement of restricted stock (in shares)				528,000
Net loss	(197,864)
Net loss after Corporate Conversion	(178,609)					(178,609)
Common stock, Ending balance (in shares) at Jul. 31, 2025				555,835,000
Stockholders' equity, ending balance at Jul. 31, 2025	$ 6,816,146			$ 56	6,994,699	(178,609)
Beginning balance of redeemable convertible unit (in shares) at Apr. 30, 2025	0
Beginning balance of redeemable convertible unit at Apr. 30, 2025	$ 0
Ending balance of redeemable convertible unit (in shares) at Jul. 31, 2025	0
Ending balance of redeemable convertible unit at Jul. 31, 2025	$ 0
Common stock, Beginning balance (in shares) at Apr. 30, 2025				555,515,000
Stockholders' equity, beginning balance at Apr. 30, 2025	6,777,783			$ 56	6,945,784	(168,057)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense after Corporate Conversion	48,915				48,915
Issuance of common stock upon settlement of restricted stock (in shares)				320,000
Net loss	(10,552)
Net loss after Corporate Conversion	(10,552)					(10,552)
Common stock, Ending balance (in shares) at Jul. 31, 2025				555,835,000
Stockholders' equity, ending balance at Jul. 31, 2025	$ 6,816,146			$ 56	6,994,699	(178,609)
Beginning balance of redeemable convertible unit (in shares) at Jan. 31, 2026	0
Beginning balance of redeemable convertible unit at Jan. 31, 2026	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Adjustment to reflect the redemption value of the redeemable convertible units	$ 0
Ending balance of redeemable convertible unit (in shares) at Jul. 31, 2026	0
Ending balance of redeemable convertible unit at Jul. 31, 2026	$ 0
Common stock, Beginning balance (in shares) at Jan. 31, 2026	563,781,636			563,487,000
Stockholders' equity, beginning balance at Jan. 31, 2026	$ 6,846,231			$ 56	7,096,974	(250,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	140,411				140,411
Issuance of common stock upon settlement of restricted stock (in shares)				7,198,000
Issuance of common stock upon settlement of restricted stock	1			$ 1
Net loss	$ (125,034)					(125,034)
Common stock, Ending balance (in shares) at Jul. 31, 2026	570,907,856			570,685,000
Stockholders' equity, ending balance at Jul. 31, 2026	$ 6,861,609			$ 57	7,237,385	(375,833)
Beginning balance of redeemable convertible unit (in shares) at Apr. 30, 2026	0
Beginning balance of redeemable convertible unit at Apr. 30, 2026	$ 0
Ending balance of redeemable convertible unit (in shares) at Jul. 31, 2026	0
Ending balance of redeemable convertible unit at Jul. 31, 2026	$ 0
Common stock, Beginning balance (in shares) at Apr. 30, 2026				567,038,000
Stockholders' equity, beginning balance at Apr. 30, 2026	6,842,157			$ 56	7,167,574	(325,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	69,811				69,811
Issuance of common stock upon settlement of restricted stock (in shares)				3,647,000
Issuance of common stock upon settlement of restricted stock	1			$ 1
Net loss	$ (50,360)					(50,360)
Common stock, Ending balance (in shares) at Jul. 31, 2026	570,907,856			570,685,000
Stockholders' equity, ending balance at Jul. 31, 2026	$ 6,861,609			$ 57	$ 7,237,385	$ (375,833)